Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 17:55:40 28/06/2024 BST			5-day change	1st Jan Change
0.1273 ^USD	-9.01%		-5.70%	-61.42%

06-25	Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	CI
06-20	Transcript : Pressure BioSciences, Inc. - Special Call

Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray

June 25, 2024 at 03:23 pm

Pressure BioSciences, Inc. announced a partnership with Vita-Forte to develop a highly bioavailable, multi-antioxidant oral spray. This breakthrough effectiveness product is expected to be commercially available by Fall 2024. According to Fortune Business Insights, the global antioxidants market size was $4.59 billion in 2023 (Antioxidant Market Size 2023).

Latest news about Pressure BioSciences, Inc.

Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	06-25	CI
Transcript : Pressure BioSciences, Inc. - Special Call	06-20
Pressure BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06-07	CI
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	02-15	CI
Transcript : CBH International LLC, Pressure BioSciences, Inc. - M&A Call	02-05
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC.	01-21	CI
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner	01-18	CI
Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC.	01-10	CI
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies	01-04	CI
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety	12-12	CI
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador	12-01	CI
Transcript : Pressure BioSciences, Inc., Q3 2023 Earnings Call, Nov 21, 2023	11-21
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Reports Q3 Revenue $413,009	11-21	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd	18/10/23	CI
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately	22/09/23	CI
Transcript : Pressure BioSciences, Inc., Q2 2023 Earnings Call, Aug 22, 2023	22/08/23
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q2 Revenue $511,800	22/08/23	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23	CI
Transcript : Pressure BioSciences, Inc. - Special Call	17/08/23
Pressure BioSciences, Inc. Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering	17/07/23	CI
Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna	10/07/23	CI
Pressure BioSciences, Inc. Announces Agreement with Somalab International LLC for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products	05/07/23	CI
Transcript : Pressure BioSciences, Inc. - Special Call	27/06/23
Pressure Biosciences, Inc. Announces Results from Third Round of Consumer Focus Group Testing of THC Nanoemulsion Oral Spray	27/06/23	CI

Chart Pressure BioSciences, Inc.

Duration

Period

More charts

Company Profile

Pressure BioSciences, Inc. is engaged in the development and sale of enabling, high pressure technology-based instruments, consumables, and services for the life sciences and other industries worldwide. Its products/services are based on three high-pressure platforms: Ultra Shear Technology (UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT). The UST platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PCT utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The BaroFold platform provides valuable contract services and GMP manufacturing equipment to the biopharmaceutical industry.

Sector

Medical Equipment, Supplies & Distribution

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PRESSURE BIOSCIENCES, INC.	-61.42%	4.42M
ABBOTT LABORATORIES	-5.60%	181B
MEDTRONIC PLC	-4.45%	101B
BECTON, DICKINSON AND COMPANY	-4.15%	67.54B
DEXCOM, INC.	-8.63%	45.09B
CENCORA, INC.	+9.70%	44.37B
HOYA CORPORATION	+6.13%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	29.85B
TERUMO CORPORATION	+14.80%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.99B

Other Medical Equipment, Supplies & Distribution